Update on antigen-specific immunotherapy of acute myeloid leukemia.
about
In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid LeukemiaThe Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.Antigen-specific immunotherapy for acute myeloid leukemia: where are we now, and where do we go from here?CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia.
P2860
Update on antigen-specific immunotherapy of acute myeloid leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Update on antigen-specific immunotherapy of acute myeloid leukemia.
@en
type
label
Update on antigen-specific immunotherapy of acute myeloid leukemia.
@en
prefLabel
Update on antigen-specific immunotherapy of acute myeloid leukemia.
@en
P2860
P1476
Update on antigen-specific immunotherapy of acute myeloid leukemia.
@en
P2093
Sarah A Buckley
P2860
P2888
P356
10.1007/S11899-015-0250-9
P577
2015-06-01T00:00:00Z
P6179
1008284798